COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ study #203 of 260
12/1 Late treatment study
Capsoni et al., Research Square, doi:10.21203/rs.3.rs-113418/v1 (Preprint)
CPAP Treatment In COVID-19 Patients: A Retrospective Observational Study In The Emergency Department
Source   PDF   Share   Tweet
Small 52 patient retrospective study of patients with acute respiratory failure showing lower rates of intubation with HCQ.

Capsoni et al., 12/1/2020, retrospective, Italy, Europe, preprint, 13 authors.
risk of ventilation, 40.0% lower, RR 0.60, p = 0.30, treatment 12 of 40 (30.0%), control 6 of 12 (50.0%).

Effect extraction follows pre-specified rules prioritizing more serious outcomes. For an individual study the most serious outcome may have a smaller number of events and lower statistical signficance, however this provides the strongest evidence for the most serious outcomes when combining the results of many trials.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit